These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 15549415)
1. "Missing" inhibitors of calcification: general aspects and implications in renal failure. Ketteler M; Westenfeld R; Schlieper G; Brandenburg V; Floege J Pediatr Nephrol; 2005 Mar; 20(3):383-8. PubMed ID: 15549415 [TBL] [Abstract][Full Text] [Related]
2. Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Moe SM; Reslerova M; Ketteler M; O'neill K; Duan D; Koczman J; Westenfeld R; Jahnen-Dechent W; Chen NX Kidney Int; 2005 Jun; 67(6):2295-304. PubMed ID: 15882271 [TBL] [Abstract][Full Text] [Related]
3. Novel insights into uremic vascular calcification: role of matrix Gla protein and alpha-2-Heremans Schmid glycoprotein/fetuin. Ketteler M; Vermeer C; Wanner C; Westenfeld R; Jahnen-Dechent W; Floege J Blood Purif; 2002; 20(5):473-6. PubMed ID: 12207096 [TBL] [Abstract][Full Text] [Related]
4. Vascular calcification inhibitors in relation to cardiovascular disease with special emphasis on fetuin-A in chronic kidney disease. Suliman ME; García-López E; Anderstam B; Lindholm B; Stenvinkel P Adv Clin Chem; 2008; 46():217-62. PubMed ID: 19004191 [TBL] [Abstract][Full Text] [Related]
5. Fetuin-A and extraosseous calcification in uremia. Ketteler M Curr Opin Nephrol Hypertens; 2005 Jul; 14(4):337-42. PubMed ID: 15931001 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms of arterial calcification: spotlight on the inhibitors. Weissen-Plenz G; Nitschke Y; Rutsch F Adv Clin Chem; 2008; 46():263-93. PubMed ID: 19004192 [TBL] [Abstract][Full Text] [Related]
7. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Shroff RC; Shah V; Hiorns MP; Schoppet M; Hofbauer LC; Hawa G; Schurgers LJ; Singhal A; Merryweather I; Brogan P; Shanahan C; Deanfield J; Rees L Nephrol Dial Transplant; 2008 Oct; 23(10):3263-71. PubMed ID: 18463323 [TBL] [Abstract][Full Text] [Related]
8. Coronary calcification in patients with end-stage renal disease: a novel endocrine disorder? Efstratiadis G; Koskinas K; Pagourelias E Hormones (Athens); 2007; 6(2):120-31. PubMed ID: 17704043 [TBL] [Abstract][Full Text] [Related]
9. Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia. Ketteler M; Wanner C; Metzger T; Bongartz P; Westenfeld R; Gladziwa U; Schurgers LJ; Vermeer C; Jahnen-Dechent W; Floege J Kidney Int Suppl; 2003 May; (84):S84-7. PubMed ID: 12694317 [TBL] [Abstract][Full Text] [Related]
10. Serum matrix Gla protein concentrations in patients with mild and severe acute pancreatitis. Kusnierz-Cabala B; Gurda-Duda A; Solnica B; Fedak D; Dumnicka P; Panek J; Kulig J Clin Lab; 2011; 57(11-12):999-1006. PubMed ID: 22239033 [TBL] [Abstract][Full Text] [Related]
11. [Calcified coronary artery disease and serum markers]. Mori K; Jono S Clin Calcium; 2007 Mar; 17(3):340-5. PubMed ID: 17339737 [TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of vascular calcification in dialysis patients. Ketteler M; Westenfeld R; Schlieper G; Brandenburg V Clin Exp Nephrol; 2005 Dec; 9(4):265-270. PubMed ID: 16362152 [TBL] [Abstract][Full Text] [Related]
13. Arteriosclerosis, calcium phosphate deposition and cardiovascular disease in uremia: current concepts at the bench. El-Abbadi M; Giachelli CM Curr Opin Nephrol Hypertens; 2005 Nov; 14(6):519-24. PubMed ID: 16205469 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of vascular calcification in renal disease. Shanahan CM Clin Nephrol; 2005 Feb; 63(2):146-57. PubMed ID: 15730057 [TBL] [Abstract][Full Text] [Related]
15. Inhibitors of calcification in blood and urine. Schlieper G; Westenfeld R; Brandenburg V; Ketteler M Semin Dial; 2007; 20(2):113-21. PubMed ID: 17374084 [TBL] [Abstract][Full Text] [Related]